Innate immunity in cystic fibrosis lung disease..pdf (942.08 kB)

Innate immunity in cystic fibrosis lung disease.

Download (942.08 kB)
journal contribution
posted on 22.11.2019, 16:28 by Dominik Hartl, Amit Gaggar, Emanuela Bruscia, Andreas Hector, Veronica Marcos, Aandreas Jung, Catherine M. Greene, Noel G. McElvaney, Marcus Mall, Gerd Döring

Chronic lung disease determines the morbidity and mortality of cystic fibrosis (CF) patients. The pulmonary immune response in CF is characterized by an early and non-resolving activation of the innate immune system, which is dysregulated at several levels. Here we provide a comprehensive overview of innate immunity in CF lung disease, involving (i) epithelial dysfunction, (ii) pathogen sensing, (iii) leukocyte recruitment, (iv) phagocyte impairment, (v) mechanisms linking innate and adaptive immunity and (iv) the potential clinical relevance. Dissecting the complex network of innate immune regulation and associated pro-inflammatory cascades in CF lung disease may pave the way for novel immune-targeted therapies in CF and other chronic infective lung diseases.

Funding

NIH (HL102371-01A1). CF Foundation (GAGGAR07A0). DFG (MA 2081/3-3 and MA 2081/4-; Emmy Noether Programme HA 5274/3-1) BMBF (DZL).

History

Comments

The original article is available at https://www.sciencedirect.com

Published Citation

Hartl D, Gaggar A, Bruscia E, Hector A, Marcos V, Jung A, Greene C, McElvaney G, Mall M, Döring G. Innate immunity in cystic fibrosis lung disease. Journal of Cystic Fibrosis. 2012;11(5):363-82.

Publication Date

01/09/2012

Publisher

Elsevier

PubMed ID

22917571

Exports